DCTH
Delcath Systems, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$16.48
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 95.4M | 85.2M | 37.2M | 2.1M | 2.7M |
| Cost of Revenue | 12.4M | 11.8M | 6.2M | 635.0K | 686.0K |
| Gross Profit | 83.1M | 73.4M | 31.0M | 1.4M | 2.0M |
| Operating Expenses | |||||
| R&D Expense | 37.6M | 29.2M | 13.9M | 17.5M | 18.6M |
| SG&A Expense | 47.3M | 43.5M | 29.6M | 22.1M | 17.3M |
| General & Admin Expense | 13.4M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 84.9M | 72.8M | 43.4M | 39.6M | 35.9M |
| Cost and Expenses | 97.2M | 84.6M | 49.6M | 40.2M | 36.6M |
| Operating Income (EBIT) | (1.8M) | 660.0K | (12.4M) | (38.2M) | (33.9M) |
| Non-Operating | |||||
| Interest Income | 3.2M | 2.9M | 125.0K | — | — |
| Interest Expense | — | — | — | 1.4M | 2.7M |
| Net Interest Income | 3.2M | 2.9M | 125.0K | (1.4M) | (2.7M) |
| Other Non-Op Income/Expense | 3.1M | 2.9M | (14.0M) | (9.5M) | (2.7M) |
| Non-Operating Income (excl Interest) | (3.1M) | (2.9M) | 14.0M | 8.1M | (30.0K) |
| EBT (Pre-Tax Income) | 1.3M | 3.5M | (26.4M) | (47.7M) | (36.5M) |
| Income Tax Expense | 760.0K | 810.0K | — | — | — |
| Bottom Line | |||||
| Net Income | 532.0K | 2.7M | (26.4M) | (47.7M) | (36.5M) |
| Earnings from Cont. Ops | 532.0K | 2.7M | (26.4M) | (47.7M) | (36.5M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 532.0K | 2.7M | (26.4M) | (47.7M) | (36.5M) |
| Per Share | |||||
| Basic EPS | $0.01 | $0.08 | ($0.11) | ($0.49) | ($4.12) |
| Diluted EPS | $0.01 | $0.07 | ($0.12) | ($0.49) | ($4.12) |
| Revenue Per Share | $2.66 | $2.38 | $1.30 | $0.13 | $0.31 |
| Shares | |||||
| Basic Shares Outstanding | 35.9M | 35.8M | 28.5M | 16.2M | 8.9M |
| Diluted Shares Outstanding | 39.8M | 39.9M | 28.5M | 16.2M | 8.9M |
| Profitability Metrics | |||||
| EBITDA | 1.7M | 3.9M | (26.2M) | (45.8M) | (33.7M) |
| D&A | 403.0K | 349.0K | 229.0K | 399.0K | 132.0K |
| EBIT | 1.3M | 3.5M | (26.4M) | (46.2M) | (33.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026